NCT07428005

Brief Summary

This study aims to develop an Italian-language questionnaire assessing awareness, knowledge of infectious risk prevention strategies, and vaccination attitudes among splenectomized individuals. The questionnaire will be developed through a structured Delphi consensus process involving a multidisciplinary panel of healthcare professionals experienced in infection prevention and vaccination strategies. Two Delphi rounds will be conducted online to evaluate item relevance and clarity. Items reaching predefined consensus thresholds will be included in the final questionnaire. The resulting tool will support future studies assessing preventive care awareness and vaccination uptake among splenectomized patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

February 17, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

splenectomyaspleniavaccinationinfection preventiondelphi studyquestionnaire development

Outcome Measures

Primary Outcomes (1)

  • Development of a consensus-based questionnaire for assessing awareness and knowledge of infectious risk prevention strategies and vaccination attitudes in splenectomized individuals.

    The outcome consists of the development of a finalized Italian questionnaire through a Delphi consensus process. As this outcome refers to the creation of a new instrument within the study, no scoring system, scale range, or interpretation of scores is applicable at this stage.

    At study completion (4 months)

Interventions

A structured Delphi consensus process involving a multidisciplinary panel of healthcare professionals aimed at developing and validating questionnaire items assessing awareness and knowledge of infectious risk prevention strategies and vaccination attitudes in splenectomized individuals. Participants evaluate questionnaire items across two online Delphi rounds, rating relevance and clarity. Items reaching predefined consensus thresholds are retained to produce the final questionnaire.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of a multidisciplinary panel of healthcare professionals, including physicians, nurses, and healthcare assistants working at Fondazione Policlinico Universitario A. Gemelli IRCCS, with clinical or academic experience in vaccination and infection prevention, particularly in the management of patients with asplenia. Participants are selected to ensure representation from different specialties involved in the care of asplenic patients and will participate in a Delphi consensus process aimed at developing a questionnaire on infectious risk prevention awareness and vaccination attitudes.

You may qualify if:

  • Healthcare professionals working at Fondazione Policlinico Universitario A. Gemelli IRCCS
  • Professional experience in vaccination or infection prevention
  • Clinical involvement in care of patients with asplenia or related conditions
  • Italian native language proficiency
  • Provision of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, Lazio, 00168, Italy

RECRUITING

Study Officials

  • LAURENTI PATRIZIA, PROFESSOR

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

LAURENTI PATRIZIA, PROFESSOR

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 17, 2026

First Posted

February 23, 2026

Study Start

January 1, 2026

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Locations